Clinical trial Recruiting at 13 sites Phase 3 Interventional Ages 60 and up

Reducing ICU Delirium with Dexmedetomidine Sleep

Official title: Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)

Run by Massachusetts General Hospital · NCT06192615 · Data updated 2026-11-12

This study is testing if a sleep-inducing medication called dexmedetomidine can help older patients recover better and avoid confusion after heart surgery in the ICU.

Quick facts

PhasePhase 3
Study typeInterventional
Ages60 Years and up
SexAll
Enrollment1800 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations14 sites (Los Angeles, California and 13 other locations)
StatusRecruiting
StartedJanuary 6, 2025
Main results expectedOctober 31, 2027
Study endsMarch 31, 2029
Registry record updatedSeptember 14, 2026
Trial IDNCT06192615 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are elderly patients aged 60 years or older who are scheduled for cardiac surgery requiring cardiopulmonary bypass and will be admitted to the ICU postoperatively.

Probably not a fit

Patients with preexisting cognitive impairments, severe liver failure, or those undergoing procedures requiring total circulatory arrest may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This phase III clinical trial evaluates the effects of intravenous and sublingual dexmedetomidine on postoperative delirium and functional outcomes in elderly patients following cardiac surgery. It employs a randomized, blinded, double placebo-controlled design with three arms to compare the efficacy of dexmedetomidine against placebo. The study aims to determine whether inducing sleep with dexmedetomidine can minimize neurological dysfunction in the ICU setting.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of delirium in elderly patients after cardiac surgery, leading to improved recovery and functional outcomes.

How similar studies have gone: Previous studies have shown promising results with dexmedetomidine in reducing delirium, suggesting that this approach may be effective, although this specific methodology is being tested in a novel context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 60 years or older
* Scheduled to undergo a cardiac surgical procedure with cardiopulmonary bypass
* Planned postoperative admission to the intensive care unit (ICU)

Exclusion Criteria:

* Allergy or hypersensitivity to dexmedetomidine or the placebo study medication
* Preexisting diagnosis of Alzheimer's Disease or Related Dementia, severe cognitive impairment or delirium at baseline
* Severe liver failure (Child-Pugh score \> 5)
* Severe deficit(s) due to structural or anoxic brain damage
* Undergoing a surgical procedure requiring total circulatory arrest
* SARS-CoV-2 positive or symptomatic (e.g., fever, cough, loss of taste/smell)
* Blind, deaf, or unable to communicate in English
* Patients experiencing circumstances for which long-term follow-up might be difficult (e.g., homelessness, active psychotic disorder, or substance abuse)
* Co-enrollment in other interventional studies that, in the opinion of the site investigator and/or PI, might interfere with study participation, collection, or interpretation of the study data

Where it's running

  • University of California San Francisco
    San Francisco, California, United States
    Recruiting
  • Northwestern University Feinberg School of Medicine
    Chicago, Illinois, United States
    Recruiting
  • University of Iowa Carver College of Medicine
    Iowa City, Iowa, United States
    Recruiting
  • University of Maryland School of Medicine
    Baltimore, Maryland, United States
    Recruiting
  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting
  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts, United States
    Recruiting
Show 8 more locations
  • Brigham and Women's Hospital
    Boston, Massachusetts, United States
    Recruiting
  • Washington University School of Medicine
    St Louis, Missouri, United States
    Recruiting
  • University of Nebraska Medical Center
    Omaha, Nebraska, United States
    Recruiting
  • Columbia University Medical Center
    New York, New York, United States
    Recruiting
  • Montefiore Medical Center
    The Bronx, New York, United States
    Recruiting
  • Duke University Hospital
    Durham, North Carolina, United States
    Recruiting
  • Vanderbilt University Medical Center
    Nashville, Tennessee, United States
    Recruiting
  • Cedars-Sinai Medical Center
    Los Angeles, California, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.